CompletedPhase 2NCT02017912
Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS
Studying Amyotrophic Lateral Sclerosis (ALS)
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Brainstorm-Cell Therapeutics
- Principal Investigator
- Merit Cudkowicz, MDMassachusetts General Hospital
- Intervention
- Nurown MSC-NTF cells(biological)
- Enrollment
- 48 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2014 – 2016
Study locations (3)
- Massachusetts General Hospital, Boston, Massachusetts, United States
- UMass Medical School, Worcester, Massachusetts, United States
- Mayo Clinic, Rochester, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02017912 on ClinicalTrials.govOther trials for Amyotrophic Lateral Sclerosis (ALS)
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07543003An International Federated Model for Wearable-derived Remote Longitudinal Motor Monitoring in Young Children With Spinal Muscular Atrophy Compared With Healthy Controls: Active-NBS Study (UK)University of Oxford
- RECRUITINGPHASE1, PHASE2NCT07017946Intestinal Microbiome Transplant in ALSDuke University
- ENROLLING BY INVITATIONNANCT07539662Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)Institute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPHASE1, PHASE2NCT07287397Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALSVector Y Therapeutics
- ACTIVE NOT RECRUITINGPHASE2NCT07023835Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral SclerosisZydus Therapeutics Inc.
- RECRUITINGNANCT07413718Inspiratory Muscle Training in Amiotrophyc Lateral SclerosisUniversity Ramon Llull
- RECRUITINGPHASE1NCT06665165AMX0114 in Adult Participants With Amyotrophic Lateral SclerosisAmylyx Pharmaceuticals Inc.
- RECRUITINGNANCT06609213Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance in pALSAndrea Charvet